Bjørn E.
- Country
- Denmark
- Department
- Mental Health Center Glostrup
Research Overview
- Efficacy of Xanomeline/Trospium in Adults with Schizophrenia for the Treatment of Cognitive Impairment: A Prospective Multicenter Study
- Long-term Safety Evaluation of Iclepertin in Schizophrenia Patients Post-Completion of Phase III Trials
- Evaluation of GT-002 and Oxazepam on Cognitive Impairment in Schizophrenia: A Phase II Randomized Controlled Trial
Data & Insights
Has run more than one trial at 6 of 93 partner sites.
Specializations
Psychotic Disorders
The investigator specializes in the treatment of first episode psychosis and schizophrenia, with particular attention to addressing both positive and negative symptoms of these conditions.
- Negative symptom management
- Cognitive impairment treatment
- Early intervention strategies
Their research encompasses innovative therapeutic approaches for managing conditions across the schizophrenia spectrum disorders.
Neurotransmitter Systems
The investigator focuses on therapeutic interventions targeting multiple neurotransmitter systems, including dopamine modulation and glutamatergic pathways in psychiatric conditions.
- Antipsychotic mechanisms
- Novel therapeutic combinations
- Neurotransmitter interactions
Their work explores the interaction between different neurotransmitter systems in treating psychotic disorders.
Clinical Innovation
The investigator explores novel therapeutic approaches in psychiatric treatment, with emphasis on addressing both cognitive and functional outcomes in psychotic disorders.
- Long-term safety assessment
- Treatment-resistant symptoms
- Therapeutic augmentation strategies
Their research includes evaluation of new compounds and combination therapies for enhanced treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.